Investing.com - Erytech Pharma ADR reported on Friday fourth quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Erytech Pharma ADR announced earnings per share of €-0.3858 on revenue of €1.42M. Analysts polled by Investing.com anticipated EPS of €-0.3858 on revenue of €1.13M.
Erytech Pharma ADR shares are down 14.05% from the beginning of the year and are trading at €1.390 , down-from-52-week-high.They are outperforming the Nasdaq which is down 17.9% from the start of the year.
Erytech Pharma ADR follows other major Healthcare sector earnings this month
Erytech Pharma ADR's report follows an earnings matched by Medtronic on Tuesday, February 22, 2022, who reported EPS of €1.37 on revenue of €7.76B, compared to forecasts EPS of €1.37 on revenue of €7.88B.
Zoetis Inc had beat expectations on Tuesday, February 15, 2022 with fourth quarter EPS of €1 on revenue of €1.97B, compared to forecast for EPS of €0.9629 on revenue of €1.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar